Natriuretic peptide receptor A mediates renal sodium excretory responses to blood volume expansion

American Journal of Physiology - Renal Physiology

Volumn 285, Issue 4 54-4, 2003, Pages

  Shi, Shang Jin ^a   Vellaichamy, Elangovan ^a   Chin, So Yeon ^a   Smithies, Oliver ^b   Navar, L Gabriel ^a   Pandey, Kailash N ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

cGMP; Gene disruption; Gene duplication; Sodium excretion

Indexed keywords

GENE PRODUCT; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE RECEPTOR A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BLOOD VOLUME; CONTROLLED STUDY; DIURESIS; GENE; GENE DISRUPTION; GENE DUPLICATION; GENE NPR1; GENOTYPE; GLOMERULUS FILTRATION RATE; HOMOZYGOSITY; KIDNEY BLOOD FLOW; KIDNEY TUBULE FUNCTION; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SODIUM EXCRETION; URINE FLOW RATE;

EID: 0141813492     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00097.2003     Document Type: Article

References (48)

1. Anand-Srivastava MB and Trachte GJ. Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacol Rev 45: 455-497, 1993.
2. Anderson JV, Christofides ND, and Bloom SR. Plasma release of atrial natriuretic peptide in response to blood volume expansion. J Endocrinol 109: 9-13, 1986.
3. Antunes-Rodrigues J, Machado BH, Andrade HA, Mauad H, Ramalho MJ, Reis LC, Silva-Netto CR, Favaretto ALA, Gutkowska J, and McCann SM. Carotid-aortic and renal baroreceptors mediate the atrial natriuretic peptide release induced by blood volume expansion. Proc Natl Acad Sci USA 89: 6829-6831, 1992.
4. Brenner BM, Ballerman BJ, Gunning ME, and Zeidel ML. Diverse biological actions of atrial natriuretic peptide. Physiol Rev 70: 665-699, 1990.
5. Burnett JC Jr, Granger JP, and Opgenorth TJ. Effects of synthetic atrial natriuretic factor on renal function and renin release. Am J Physiol Renal Fluid Electrolyte Physiol 247: F863-F866, 1984.
6. Cervenka L, Mitchell KD, and Navar LG. Renal function in mice: effects of volume expansion and angiotensin II. J Am Soc Nephrol 10: 2631-2636, 1999.
7. Chen HH, Lainchbury JG, Matsuda Y, Harty GJ, and Burnett JC Jr. Endogenous natriuretic peptides participate in renal and humoral actions of acute vasopeptidase inhibition in experimental mild heart failure. Hypertension 38: 187-191, 2001.
8. De Bold AJ. Atrial natriuretic factor: a hormone produced by the heart. Science 230: 767-770, 1985.
9. Delporte C, Winand J, Poloczek P, von Geldern T, and Christophe J. Discovery of a potent atrial natriuretic peptide receptor antagonist for NPRA in the human neuroblastoma NB-OK-1 cell line. Eur J Pharmacol 224: 183-188, 1992.
10. Drewett JG and Garbers DL. The family of guanylyl cyclase receptors and their ligands. Endocr Rev 15: 135-162, 1994.
11. Garbers DL. Guanylyl cyclase receptors and their endocrine, paracrine, and autocrine ligands. Cell 71: 1-4, 1992.
12. Holtwick R, Baba HA, Ehler E, Risse Vob MD, Gehrmann J, Pierkes M, and Kuhn M. Left but not right cardiac hypertrophy in atrial natriuretic peptide receptor-deficient mice is prevented by angiotensin type 1 receptor antagonist losartan. J Cardiovasc Pharmacol 40: 725-734, 2002.
13. Holtwick R, Gotthardt M, Skryabin B, Steinmetz M, Potthast R, Zetsche B, Hammer RE, Herz J, and Kuhn M. Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure. Proc Natl Acad Sci USA 99: 7142-7147, 2002.
14. John SW, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC, Flynn TG, and Smithies O. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267: 679-681, 1995.
15. Kim HS, Lu G, John SWM, Maeda N, and Smithies O. Molecular phenotyping for analyzing subtle genetic effects in mice: application to an angiotensinogen gene titration. Proc Natl Acad Sci USA 99: 4602-4607, 2002.
16. Kishimoto I, Dubois SK, and Garbers DL. The heart communicates with the kidney exclusively through the guanylyl cyclase-A receptor: acute handling of sodium and water in response to volume expansion. Proc Natl Acad Sci USA 93: 6215-6219, 1996.
17. Kishimoto I, Rossi K, and Garbers DL. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy. Proc Natl Acad Sci USA 98: 2703-2706, 2001.
18. Knowles JW, Esposito G, Mao L, and Smithies O. Pressurein-dependent enhancement of cardiac hypertrophy in natriuretic peptide receptor-A deficient mice. J Clin Invest 107: 975-984, 2001.
19. Koller KJ and Goeddel DV. Molecular biology of the natriuretic peptides and their receptors. Circulation 86: 1081-1088, 1992.
20. Levin ER, Gardner DG, and Samson WK. Natriuretic peptides. N Engl J Med 339: 321-328, 1998.
21. Lopez MJ, Wong SK, Kishimoto I, Dubois S, Mach V, Friesen J, Garbers DL, and Beuve A. Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature 378: 65-68, 1995.
22. Lucas KA, Pitari GM, Dazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepenic KP, and Waldman SA. Guanylyl cyclase and signaling by cyclic-GMP. Pharmacol Rev 52: 375-413, 2000.
23. McCann SM, Gutkowska J, and Antunes-Rodrigues J. Neuroendocrine control of body fluid homeostasis. Braz J Med Biol Res 36: 165-181, 2003.
24. Melo LG, Veress AT, Ackermann U, Steinhelper ME, Pang SC, Tse Y, and Sonnenberg H. Chronic regulation of arterial blood pressure in ANP transgenic and knockout mice: role of cardiovascular sympathetic tone. Cardiovasc Res 43: 437-444, 1999.
25. Meyer M and Forssmann G. Renal action of natriuretic peptides. In: Natriuretic Peptides in Health and Disease, edited by Samson WK and Levin ER. Totowa, NJ: Humana, 1997, p. 147-170.
26. Misono KS. Atrial natriuretic factor binding to its receptor is dependent on chloride concentration: a possible feedback control mechanism in renal salt regulation. Circ Res 86: 1135-1139, 2000.
27. Navar LG. The kidney in blood pressure regulation and development of hypertension. Med Clin North Am 81: 1165-1198, 1997.
28. Navar LG and Hamm LL. The kidney in blood pressure regulation. In: Atlas of Diseases of Kidney. Hypertension and the Kidney, edited by Cox CS. Philadelphia: Current Medicine, 1999, vol. 3, p. 1.1-1.22.
29. Obana K, Naruse N, Naruse K, Sakurai H, Demura H, Inagami T, and Shizume K. Synthetic rat atrial natriuretic factor inhibits in vitro and in vivo renin secretion in rats. Endocrinology 117: 1282-1284, 1985.
30. Ohyama Y, Miyamoto K, Morishita Y, Matsuda Y, Saito Y, Minamino N, Kangawa K, and Matsuo H. Stable expression of natriuretic peptide receptors: effects of HS-142-1, a nonpeptide ANP antagonist. Biochem Biophys Res Commun 189: 336-342, 1992.
31. Oliver PM, Fox JE, Kim R, Rockman HA, Kim HS, Reddick RL, Pandey KN, Milgram SL, Smithies O, and Maeda N. Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci USA 94: 14730-14735, 1997.
32. Oliver PM, John SW, Purdy KE, Kim R, Maeda N, Goy MF, and Smithies O. Natriuretic peptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner. Proc Natl Acad Sci USA 95: 2547-2551, 1998.
33. Pandey KN. Vascular action of natriuretic peptide receptor. In: Contemporary Endocrinology of the Vascularture, edited by Sowers JR. Totowa, NJ: Humana, 1996, p. 255-267.
34. Pandey KN and Inagami T. Regulation of renin and angiotensins by gonadotropic hormones in cultured murine Leydig tumor cells. Release of angiotensins but not renin. J Biol Chem 261: 3934-3938, 1986.
35. Pandey KN, Kumar R, Li M, and Nguyen H. Functional domains and expression of truncated atrial natriuretic peptide receptor-A: the carboxyl-terminal regions direct the receptor internalization and sequestration in COS-7 cells. Mol Pharmacol 57: 259-267, 2000.
36. Pandey KN, Nguyen HT, Sharma GD, Shi SJ, and Kriegel AM. Ligand-regulated internalization, trafficking, and down-regulation of guanylyl cyclase/atrial natriuretic peptide receptor-A in human embryonic kidney 293 cells. J Biol Chem 277: 4618-4627, 2002.
37. Pandey KN, Oliver PM, Maeda N, and Smithies O. Hypertension associated with decreased testosterone levels in natriuretic peptide receptor-A gene-knockout and gene-duplicated mutant mouse models. Endocrinology 140: 5112-5119, 1999.
38. Pandey KN and Orgebin-Crist MC. Atrial natriuretic factor in mammalian testis: immunological detection in spermatozoa. Biochem Biophys Res Commun 180: 437-444, 1991.
39. Pandey KN and Singh S. Molecular cloning and expression of murine guanylate cyclase/atrial natriuretic factor receptor cDNA. J Biol Chem 265: 12342-12348, 1990.
40. Paul RV, Ferguson T, and Navar LG. ANF secretion and renal responses to volume expansion with equilibrated blood. Am J Physiol Renal Fluid Electrolyte Physiol 255: F936-F943, 1988.
41. Schulz S, Singh S, Bellet RA, Singh G, Tubb DJ, Chin H, and Garbers DL. The primary structure of a plasma membrane guanylyl cyclase demonstrates diversity within this new receptor family. Cell 58: 1155-1162, 1989.
42. Schwab TR, Edwards BS, Heublein DM, and Burnett JC Jr. Role of atrial natriuretic peptide in volume-expansion natriuresis. Am J Physiol Regul Integr Comp Physiol 251: R310-R313, 1986.
43. Sharma RK. Evolution of the membrane guanylate cyclase transduction system. Mol Cell Biochem 230: 3-30, 2002.
44. Shi SJ, Nguyen HT, Sharma GD, Navar LG, and Pandey KN. Genetic disruption of atrial natriuretic peptide receptor-A alters renin and angiotensin II levels. Am J Physiol Renal Physiol 281: F665-F673, 2001.
45. Takahashi N and Smithies O. Gene-targeting approaches to analyzing hypertension. J Am Soc Nephrol 10: 1598-1605, 1999.
46. Wilkins MR, Redondo J, and Brown LA. The natriuretic peptide family. Lancet 349: 1307-1310, 1997.
47. Zeidel ML. Hormonal regulation of inner medullary collecting duct sodium transport. Am J Physiol Renal Fluid Electrolyte Physiol 265: F159-F173, 1993.
48. Zhao L, Long L, and Morrell NW. NPRA-deficient mice show increased susceptibility to hypoxia-induced pulmonary hypertension. Circulation 99: 605-607, 1999.